Cambridgeshire, United Kingdom

John Stephen Robinson

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Stephen Robinson. Retrieved from https://idiyas.com/inventor/john-stephen-robinson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

 

 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 28(Granted Patents)


Location History:

  • Cambridge, GB (2015 - 2016)
  • Cambridgeshire, GB (2017 - 2020)

Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of John Stephen Robinson

Introduction

John Stephen Robinson is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as orexin receptor antagonists. With a total of 5 patents to his name, Robinson's work has the potential to impact therapeutic applications significantly.

Latest Patents

Robinson's latest patents include innovative compounds of formula (I) that are designed as orexin receptor antagonists. These inventions provide pharmaceutically acceptable salts and outline processes for their preparation. The pharmaceutical compositions containing these compounds are intended for use in therapy, showcasing Robinson's commitment to advancing medical science.

Career Highlights

Robinson is currently associated with Takeda Pharmaceutical Company Limited, where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing new therapeutic options that could benefit patients suffering from various conditions.

Collaborations

Robinson collaborates with talented coworkers, including Charlotte Fieldhouse and Angela Glen. Their combined expertise fosters an environment of innovation and creativity, leading to groundbreaking advancements in their field.

Conclusion

John Stephen Robinson's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work on orexin receptor antagonists exemplifies the potential of scientific research to improve therapeutic outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…